2014年 AbMole首次被 Nature和Nature Medicine 引用
Targeting APC loss using synthetic lethality in Colorectal Cancer 【IF: 0】Queen Mary University of London. 2018 Feb Moxifloxacin hydrochloride 购买自AbMole
Patent. JP2018027959A 【IF: 0】Patent. JP2018027959A 2018 Feb 22 Tofacitinib 购买自AbMole
Patent. US2018291378A1 【IF: 0】Patent. US2018291378A1 2018 Oct 11 Tofacitinib 购买自AbMole
2036 Extracellular matrix as a novel approach to glioma therapy 【IF: 0】J Clin Transl Sci. 2018 Nov 21;Vol2, Supplement S1, pp.11-12 Temozolomide 购买自AbMole
Orthotopic patient-derived xenografts of paediatric solid tumours 【IF: 69.504】Nature. 2017 Sep 7;549(7670):96-100 Adavosertib (MK-1775) 购买自AbMole
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 【IF: 69.504】Nature. 2017 Dec 6 NMS-873 购买自AbMole
The target landscape of clinical kinase drugs 【IF: 63.714】Science. 2017 Dec 1;358(6367) X-376 购买自AbMole
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models 【IF: 41.444】Mol Cancer. 2017 May 22;16(1):93 GDC-0941 (Pictilisib) 购买自AbMole
Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer’s disease 【IF: 14.957】Sci Adv. 2017 Feb 24;3(2):e1601068 Semagacestat 购买自AbMole
SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling 【IF: 13.965】Circ Res. 2017 Jul 31 DAPT 购买自AbMole
Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer 【IF: 13.312】Cancer Res. 2017 Jan 1;77(1):41-52 Capmatinib (INCB28060) 购买自AbMole
ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma. 【IF: 13.312】Cancer Res. 2017 Jun 1;77(11):3040-3056 VE-822 (Berzosertib) 购买自AbMole
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2025 AbMole版权所有
沪ICP备16047849号 沪公网安备 31011502012228号